Product Overview
Hyloric is a pharmaceutical formulation containing Allopurinol as its active ingredient, presented in tablet dosage form. This medication is extensively prescribed for the management of gout and related disorders characterized by elevated serum uric acid concentrations. Allopurinol functions by inhibiting uric acid synthesis, thereby preventing the deposition of urate crystals in articular joints and renal tissue, which are responsible for gouty arthritis and nephrolithiasis respectively.
Therapeutic Indications
Hyloric tablets are principally indicated for:
- Treatment and prophylaxis of gouty arthritis
- Management of uric acid nephrolithiasis
- Control of hyperuricemia secondary to chemotherapy
This medication is particularly valuable for patients experiencing recurrent gout episodes or those susceptible to complications arising from persistent hyperuricemia.
Administration Guidelines
For optimal therapeutic outcomes:
- Administer orally with 200-250mL of water
- Preferably consume postprandially to mitigate gastrointestinal irritation
- Maintain strict adherence to prescribed dosing regimen
- Swallow tablets intact – do not crush, chew, or divide
Mechanism of Action
Allopurinol exerts its pharmacological effect through competitive inhibition of xanthine oxidase, the rate-limiting enzyme in uric acid biosynthesis. This inhibition results in:
- Reduced serum urate concentrations
- Decreased urate crystal formation
- Prevention of acute gout flares
- Inhibition of uric acid calculi development
Dosage Protocol
Standard dosing recommendations:
Indication | Initial Dose | Maintenance Dose |
---|---|---|
Gout | 100mg daily | 100-300mg daily |
Hyperuricemia | 100-200mg daily | 200-600mg daily |
Note: Dosage must be individualized based on renal function and therapeutic response.
Therapeutic Advantages
- Proven efficacy in acute and chronic gout management
- Significant reduction in tophaceous deposits
- Prevention of uric acid nephropathy
- Decreased frequency of arthritic flares
- Improved patient mobility and quality of life
Adverse Effects
Frequently reported undesirable effects include:
- Gastrointestinal disturbances (nausea, diarrhea)
- Transient cutaneous eruptions
- Mild cephalalgia
- Hepatic enzyme elevation
Most adverse reactions are self-limiting and diminish with continued therapy.
Precautions
Special considerations:
- Monitor hepatic function periodically
- Maintain adequate hydration (2-3L daily)
- Assess renal function before initiation
- Caution in patients with HLA-B*5801 allele
Contraindications
Hyloric is contraindicated in:
- Hypersensitivity to allopurinol or excipients
- Concurrent use with azathioprine or mercaptopurine
- Severe hepatic impairment
- Acute gout attacks (initiation phase)
Storage Conditions
Optimal storage parameters:
- Temperature: 15-30°C
- Protect from moisture and light
- Maintain in original packaging
- Keep out of pediatric reach
Medical Disclaimer
The information provided herein represents carefully curated, evidence-based data that has undergone rigorous medical review. However, this content:
- Does not constitute medical advice
- Should not replace professional clinical judgment
- May not encompass all potential adverse effects
- Does not account for individual patient variability
Patients are strongly advised to consult qualified healthcare providers for personalized medical guidance. This information serves as an educational supplement to, not a substitute for, the physician-patient relationship.